When a drug developer loses a partner, there's actually a 50-50 chance that the drug will remain in development, according to a new study of deals data from Informa’s Strategic Transactions . And of
IN VITRO DIAGNOSTICS Mergers & Acquisitions Eurofins Scientific SE Boston Heart Diagnostics Corp. Gaining a foothold in the cardiology diagnostics space, Eurofins Scientific SE acquired Boston H